|
1
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2021. CA Cancer J Clin. 71:7–33.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Mottet N, Bellmunt J, Bolla M, Briers E,
Cumberbatch MG, De Santis M, Fossati N, Gross T, Henry AM, Joniau
S, et al: EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1:
Screening, diagnosis, and local treatment with curative intent. Eur
Urol. 71:618–629. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Koontz BF, Bossi A, Cozzarini C, Wiegel T
and D'Amico A: A systematic review of hypofractionation for primary
management of prostate cancer. Eur Urol. 68:683–691.
2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Jackson WC, Silva J, Hartman HE, Dess RT,
Kishan AU, Beeler WH, Gharzai LA, Jaworski EM, Mehra R, Hearn JWD,
et al: Stereotactic body radiation therapy for localized prostate
cancer: A systematic review and meta-analysis of over 6,000
patients treated on prospective studies. Int J Radiat Oncol Biol
Phys. 104:778–789. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Susil RC, McNutt TR, DeWeese TL and Song
D: Effects of prostate-rectum separation on rectal dose from
external beam radiotherapy. Int J Radiat Oncol Biol Phys.
76:1251–1258. 2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hamstra DA, Mariados N, Sylvester J, Shah
D, Karsh L, Hudes R, Beyer D, Kurtzman S, Bogart J, Hsi RA, et al:
Continued benefit to rectal separation for prostate radiation
therapy: Final results of a phase III trial. Int J Radiat Oncol
Biol Phys. 97:976–985. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chao M, Ho H, Chan Y, Tan A, Pham T,
Bolton D, Troy A, Temelcos C, Sengupta S, McMillan K, et al:
Prospective analysis of hydrogel spacer for patients with prostate
cancer undergoing radiotherapy. BJU Int. 122:427–433.
2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bolla M, Maingon P, Carrie C, Villa S,
Kitsios P, Poortmans PM, Sundar S, van der Steen-Banasik EM,
Armstrong J, Bosset JF, et al: Short androgen suppression and
radiation dose escalation for intermediate- and high-risk localized
prostate cancer: Results of EORTC trial 22991. J Clin Oncol.
34:1748–1756. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ng M, Brown E, Williams A, Chao M,
Lawrentschuk N and Chee R: Fiducial markers and spacers in prostate
radiotherapy: Current applications. BJU Int. 113 (Suppl 2):S13–S20.
2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Salembier C, Villeirs G, De Bari B, Hoskin
P, Pieters BR, Van Vulpen M, Khoo V, Henry A, Bossi A, De Meerleer
G and Fonteyne V: ESTRO ACROP consensus guideline on CT- and
MRI-based target volume delineation for primary radiation therapy
of localized prostate cancer. Radiother Oncol. 127:49–61.
2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
De Meerleer GO, Villeirs GM, Vakaet L,
Delrue LJ and De Neve WJ: The incidence of inclusion of the sigmoid
colon and small bowel in the planning target volume in radiotherapy
for prostate cancer. Strahlenther Onkol. 180:573–581.
2004.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Fonteyne V, De Neve W, Villeirs G, De
Wagter C and De Meerleer G: Late radiotherapy-induced lower
intestinal toxicity (RILIT) of intensity-modulated radiotherapy for
prostate cancer: The need for adapting toxicity scales and the
appearance of the sigmoid colon as co-responsible organ for lower
intestinal toxicity. Radiother Oncol. 84:156–163. 2007.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Fischer-Valuck BW, Chundury A, Gay H,
Bosch W and Michalski J: Hydrogel spacer distribution within the
perirectal space in patients undergoing radiotherapy for prostate
cancer: Impact of spacer symmetry on rectal dose reduction and the
clinical consequences of hydrogel infiltration into the rectal
wall. Pract Radiat Oncol. 7:195–202. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Pinkawa M, Klotz J, Djukic V, Schubert C,
Escobar-Corral N, Caffaro M, Piroth MD, Holy R and Eble MJ:
Learning curve in the application of a hydrogel spacer to protect
the rectal wall during radiotherapy of localized prostate cancer.
Urology. 82:963–968. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Fukumitsu N, Mima M, Demizu Y, Suzuki T,
Ishida T, Matsushita K, Yamaguchi R, Fujisawa M and Soejima T:
Separation effect and development of implantation technique of
hydrogel spacer for prostate cancers. Pract Radiat Oncol.
12:226–235. 2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Catton CN, Lukka H, Gu CS, Martin JM,
Supiot S, Chung PWM, Bauman GS, Bahary JP, Ahmed S, Cheung P, et
al: Randomized trial of a hypofractionated radiation regimen for
the treatment of localized prostate cancer. J Clin Oncol.
35:1884–1890. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Arcangeli G, Saracino B, Arcangeli S,
Gomellini S, Petrongari MG, Sanguineti G and Strigari L: Moderate
hypofractionation in high-risk, organ-confined prostate cancer:
Final results of a phase III randomized trial. J Clin Oncol.
35:1891–1897. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Datta NR, Stutz E, Rogers S and Bodis S:
Conventional versus hypofractionated radiation therapy for
localized or locally advanced prostate cancer: A systematic review
and meta-analysis and therapeutic implications. Int J Radiat Oncol
Biol Phys. 99:573–589. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Brand VJ, Milder MTW, Christianen MEMC,
Hoogeman MS and Incrocci L: Seminal vesicle inter- and
intra-fraction motion during radiotherapy for prostate cancer: A
review. Radiother Oncol. 169:15–24. 2022.PubMed/NCBI View Article : Google Scholar
|
